Randomized Study of Botulinum Toxin Type A for Achalasia

NCT00004416 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2015-03-25

No results posted yet for this study

Summary

OBJECTIVES: I. Compare the efficacy of two doses of botulinum toxin in the treatment of achalasia.

II. Compare the safety of these two doses in these patients.

Conditions

  • Esophageal Achalasia

Interventions

DRUG

botulinum toxin type A

Sponsors & Collaborators

  • University of Texas

    lead OTHER

Principal Investigators

  • Pankaj Jay Pasricha · University of Texas

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-01-31
Completion
2002-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004416 on ClinicalTrials.gov